Quarterly Results

Date Title and Summary
Toggle Summary Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders
MISSISSAUGA, Ontario , June 29, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc.  (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced the results of the matters voted upon at the Company's 2018 annual meeting (the "Meeting") of the shareholders of the Company (the "Shareholders")
Toggle Summary Aralez Announces First Quarter 2018 Financial Results
-1Q 2018 Net Revenues Increased to $38.1 Million Versus $26.0 Million in 1Q 2017- MISSISSAUGA, Ontario , May 8, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (" Aralez " or the " Company ") today announced financial results for the first quarter ending March 31, 2018 .
Toggle Summary Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results
-4Q 2017 Net Revenues Increased to $28.0 Million Versus $20.0 Million in the 4Q 2016- -Full-Year Net Revenues Increased to $105.9 Million Versus $54.3 Million in Full-Year 2016- -Provides 2018 Full-Year Financial Guidance- MISSISSAUGA, Ontario , March 13, 2018 /PRNewswire/ -- Aralez Pharmaceuticals
Toggle Summary Aralez Announces Third Quarter 2017 Financial Results And Achieves Profitability on an Adjusted EBITDA Basis for the First Time in the Third Quarter
  -3Q 2017 Net Revenues of $24.3 Million ; Year-to-Date 2017 Net Revenues of $77.9 Million -   -Implements Fiscal Improvements designed to Deliver Profitability, Support Growth & Extend Cash Runway- -Provides Updated 2017 Full-Year Guidance and Preliminary 2018 Full-Year Outlook- MISSISSAUGA,

Data Provided by Refinitiv. Minimum 15 minutes delayed.